StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
SAENTER.BO$48.47+0.00%
Fair $48.47+0.0%

SAENTER.BO

South Asian Enterprises Limited

Technology / Electronic ComponentsBSE

$48.47

+0.00 (+0.00%)

Fairly Valued+0.0%Fair Value $48.47Fund rank 26/100 · Data gapFallback financials|
SA 11/F
F-Score: 2/9
Low Profitability

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 34% · confianza 17%

FCF escenarios

weak_data · normalized FCF $-7.0M · quality 41.7/100

Data gap 26/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 22/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

11/100

F

Piotroski

2/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. ROE is -4.7%, below the 5% threshold
Thesis & Journal · SAENTER.BOLocal privado en este navegador · South Asian Enterprises Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$194M

P/E

N/A

•

EV/EBITDA

N/A

•

ROE

-4.7%

↓

Gross Margin

35.5%

↑

Debt/Equity

N/A

•
52-Week Range$48
$23$57

TradingView lightweight chart

SAENTER.BO price, volumen y niveles de valoración

Último $48.47Periodo -9.0%
Fair value: $48.47

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2023–2026 · 3 años de histórico normalizado

Revenue CAGR

-60.1%

FCF CAGR

—

FCF margin

-70.4%

FCF / Net income

1.66x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $3.6M · net income $-1.5M · FCF $-2.5M

2023-FY → 2026-FY

Gross margin

35.5%-28.7% pts

Operating margin

-130.4%-96.0% pts

Net margin

-42.4%-21.2% pts

FCF margin

-70.4%-42.4% pts
MetricTTM
2026
2025
2024
2023
Income Statement
Revenue$3.6M$3.6M$2.5M$51.7M$56.6M
Net Income$-1.5M$-1.5M$-33.4M$-8.8M$-12.0M
EBITDA$-738000.00$-738000.00$-34.0M$-1.4M$-7.5M
EPS——-0.38-2.19-3.01
Gross Margin35.5%35.5%38.2%66.5%64.2%
Operating Margin-130.4%-130.4%-258.5%-30.7%-34.3%
Net Margin-42.4%-42.4%-1330.9%-16.9%-21.2%
Balance Sheet
Debt/Equity———1.010.85
Current Ratio60.6460.64———
Cash Flow
Free Cash Flow$-2.5M$-2.5M$-7.0M$-14.1M$-15.9M
Returns
ROE-4.7%-4.7%-97.5%-21.3%-24.2%
Valuation
P/B5.935.935.85——
Growth & Yield
Revenue Growth43.9%43.9%-95.2%-8.7%—
EPS Growth——82.6%27.2%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%
Reverse DCF requires positive EPS; loss-making or zero-EPS companies cannot produce a clean EPS hurdle.

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +2.8%

Total return

+2.8%

Start / end P/E

n/dx → n/dx

EPS bridge

-0.38 → n/d

Residual

+2.8%

EPS growthn/d
Multiple reratingn/d
Dividend+0.0%
Residual / FX / buybacks / cross-term+2.8%

EPS/multiple decomposition requires positive EPS at both endpoints; residual absorbs price move not explained by dividends.

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.